These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 21944894

  • 1. Levetiracetam clinical pharmacokinetics in elderly and very elderly patients with epilepsy.
    Contin M, Mohamed S, Albani F, Riva R, Baruzzi A.
    Epilepsy Res; 2012 Feb; 98(2-3):130-4. PubMed ID: 21944894
    [Abstract] [Full Text] [Related]

  • 2. Effect of age and comedication on levetiracetam pharmacokinetics and tolerability.
    Hirsch LJ, Arif H, Buchsbaum R, Weintraub D, Lee J, Chang JT, Resor SR, Bazil CW.
    Epilepsia; 2007 Jul; 48(7):1351-9. PubMed ID: 17573925
    [Abstract] [Full Text] [Related]

  • 3. No effect of oral contraceptives on the metabolism of levetiracetam.
    Sabers A, Christensen J.
    Epilepsy Res; 2011 Aug; 95(3):277-9. PubMed ID: 21549563
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of levetiracetam in infants and young children with epilepsy.
    Glauser TA, Mitchell WG, Weinstock A, Bebin M, Chen D, Coupez R, Stockis A, Lu ZS.
    Epilepsia; 2007 Jun; 48(6):1117-22. PubMed ID: 17442002
    [Abstract] [Full Text] [Related]

  • 5. Influence of enzyme inducing antiepileptic drugs on the pharmacokinetics of levetiracetam in patients with epilepsy.
    Freitas-Lima P, Alexandre V, Pereira LR, Feletti F, Perucca E, Sakamoto AC.
    Epilepsy Res; 2011 Mar; 94(1-2):117-20. PubMed ID: 21282041
    [Abstract] [Full Text] [Related]

  • 6. Tolerability and efficacy of oral loading of levetiracetam.
    Koubeissi MZ, Amina S, Pita I, Bergey GK, Werz MA.
    Neurology; 2008 May 27; 70(22 Pt 2):2166-70. PubMed ID: 18505995
    [Abstract] [Full Text] [Related]

  • 7. Population pharmacokinetics of levetiracetam and dosing recommendation in children with epilepsy.
    Chhun S, Jullien V, Rey E, Dulac O, Chiron C, Pons G.
    Epilepsia; 2009 May 27; 50(5):1150-7. PubMed ID: 19175400
    [Abstract] [Full Text] [Related]

  • 8. Levetiracetam monotherapy for late poststroke seizures in the elderly.
    Kutlu G, Gomceli YB, Unal Y, Inan LE.
    Epilepsy Behav; 2008 Oct 27; 13(3):542-4. PubMed ID: 18539085
    [Abstract] [Full Text] [Related]

  • 9. Saliva and serum levetiracetam concentrations in patients with epilepsy.
    Mecarelli O, Li Voti P, Pro S, Romolo FS, Rotolo M, Pulitano P, Accornero N, Vanacore N.
    Ther Drug Monit; 2007 Jun 27; 29(3):313-8. PubMed ID: 17529888
    [Abstract] [Full Text] [Related]

  • 10. Phenobarbital pharmacokinetics in old age: a case-matched evaluation based on therapeutic drug monitoring data.
    Messina S, Battino D, Croci D, Mamoli D, Ratti S, Perucca E.
    Epilepsia; 2005 Mar 27; 46(3):372-7. PubMed ID: 15730534
    [Abstract] [Full Text] [Related]

  • 11. Age and comedications influence levetiracetam pharmacokinetics in children.
    Dahlin MG, Wide K, Ohman I.
    Pediatr Neurol; 2010 Oct 27; 43(4):231-5. PubMed ID: 20837299
    [Abstract] [Full Text] [Related]

  • 12. Levetiracetam therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs.
    Contin M, Albani F, Riva R, Baruzzi A.
    Ther Drug Monit; 2004 Aug 27; 26(4):375-9. PubMed ID: 15257066
    [Abstract] [Full Text] [Related]

  • 13. Serum concentration/dose ratio of levetiracetam before, during and after pregnancy.
    Westin AA, Reimers A, Helde G, Nakken KO, Brodtkorb E.
    Seizure; 2008 Mar 27; 17(2):192-8. PubMed ID: 18180176
    [Abstract] [Full Text] [Related]

  • 14. Levetiracetam compared to valproic acid: plasma concentration levels, adverse effects and interactions in aneurysmal subarachnoid hemorrhage.
    Mink S, Muroi C, Seule M, Bjeljac M, Keller E.
    Clin Neurol Neurosurg; 2011 Oct 27; 113(8):644-8. PubMed ID: 21703756
    [Abstract] [Full Text] [Related]

  • 15. Intravenous levetiracetam in children with seizures: a prospective safety study.
    Ng YT, Hastriter EV, Cardenas JF, Khoury EM, Chapman KE.
    J Child Neurol; 2010 May 27; 25(5):551-5. PubMed ID: 20413804
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of levetiracetam during pregnancy, delivery, in the neonatal period, and lactation.
    Tomson T, Palm R, Källén K, Ben-Menachem E, Söderfeldt B, Danielsson B, Johansson R, Luef G, Ohman I.
    Epilepsia; 2007 Jun 27; 48(6):1111-6. PubMed ID: 17381438
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Onset of action of levetiracetam: a RCT trial using therapeutic intensive seizure analysis (TISA).
    Stefan H, Wang-Tilz Y, Pauli E, Dennhöfer S, Genow A, Kerling F, Lorber B, Fraunberger B, Halboni P, Koebnick C, Gefeller O, Tilz C.
    Epilepsia; 2006 Mar 27; 47(3):516-22. PubMed ID: 16529615
    [Abstract] [Full Text] [Related]

  • 19. The influence of old age and enzyme inducing comedication on the pharmacokinetics of valproic acid at steady-state: A case-matched evaluation based on therapeutic drug monitoring data.
    Fattore C, Messina S, Battino D, Croci D, Mamoli D, Perucca E.
    Epilepsy Res; 2006 Aug 27; 70(2-3):153-60. PubMed ID: 16730950
    [Abstract] [Full Text] [Related]

  • 20. Population pharmacokinetics and dose-response relationship of levetiracetam in adult patients with epilepsy.
    Rhee SJ, Shin JW, Lee S, Moon J, Kim TJ, Jung KY, Park KI, Lee ST, Jung KH, Yu KS, Jang IJ, Chu K, Lee SK.
    Epilepsy Res; 2017 May 27; 132():8-14. PubMed ID: 28279893
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.